admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Filament Health Announces Co-Development and Exclusive Licensing Agreement with Entheotech Bioscience

Psychedelic Bypassing: When Avoidance is Mistaken for Healing

MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease

The Serotonin 5-HT2A Receptor: From Mice to Humans

CaaMTech Teams Up With University of Wyoming to Study Psychedelics as...

Awakn Life Sciences Signs MOU with NHS (Devon Partnership NHS Trust)...

PT273 – Erica Rex – Clinical Trials and Spontaneous Mystical Experiences

MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive...

Filament Health Reports Third Quarter 2021 Financial Results and Operational Highlights

Field Trip Health Ltd. Reports Second Fiscal Quarter 2022 Financial Results...

1...180181182...218 Page 181 of 218

Colorado’s Psilocybin Supply Chain Complete: First Testing Lab Licensed, Sessions Could...

Pα+ Psychedelic Bulletin #196: Otsuka Eyes Psychedelic Future in Japan; First...

EXCLUSIVE: Heroic Hearts and Healing Breakthrough Merge to Expand Stateside Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin